RA
VSEEW

Ramius Advisors’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

Ramius Advisors’s Portfolio VSEEW Stock Details VSEEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-145,400
Closed -$21K – 193
2022
Q3 		$21K Hold
145,400
– – 0.01% 72
2022
Q2 		$16K Buy
+145,400
New +$20.8K 0.01% 141

Other funds holding VSEEW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ramius Advisors's VSEEW Position: Q4 2022 in Review

Ramius Advisors sold out of VSEE HEALTH INC WTS 29 (VSEEW) in Q4 2022, closing a stake of 145,400 shares — an estimated $21K sold.

Ramius Advisors first reported a position in VSEEW in Q2 2022 and held it in 2 quarters. The position peaked at $21K in Q3 2022. 31 funds tracked by Wall St. Rank hold VSEEW as of Q4 2022.

  • Ramius Advisors reported no remaining VSEE HEALTH INC WTS 29 position as of Q4 2022 after selling out during the quarter.
  • Ramius Advisors sold 145,400 VSEE HEALTH INC WTS 29 shares in Q4 2022, an estimated $21K.
  • Ramius Advisors first reported a position in VSEE HEALTH INC WTS 29 in Q2 2022 and held it in 2 quarters.
  • Ramius Advisors's VSEE HEALTH INC WTS 29 position peaked at $21K in Q3 2022.
  • 31 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q4 2022.

Based on Ramius Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.